Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102675283A reveals a novel acid-catalyzed condensation route for Bepotastine intermediates, offering superior chiral purity and yield compared to traditional base-mediated methods.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111732553B reveals a novel liquid-phase synthesis for fenoxaprop-p-ethyl, offering high purity and efficient solvent recovery for cost-effective manufacturing.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107557412B details a continuous immobilized enzyme method for NADPH synthesis, offering high purity and cost reduction in biopharmaceutical manufacturing.
Patent CN106588746B reveals a green hydrogenation route for Gliclazide side chain. Offers high purity, catalyst recycling, and cost reduction for pharmaceutical manufacturing.
Novel ionic liquid method for cyclopentanone production offering high selectivity and catalyst recycling for fine chemical supply chains.
Patent CN113403350A reveals a novel enzymatic route for high-purity acetylhydroxyproline, offering significant cost reduction and scalable manufacturing for the cosmetic industry.
Patent CN114394913B introduces a metal-free heteropolyacid catalyzed synthesis of oxime ethers. This method offers significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN114958699A reveals a novel dual-enzyme co-expression strategy for ursodeoxycholic acid, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Novel biomass-derived route for 4-methylbenzaldehyde using ionic liquids and graphite oxide catalysts ensures cost reduction and supply chain reliability for global buyers.
Patent CN107557412A details immobilized enzyme catalysis for NADPH. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN105200076A reveals high-purity gamma-lactam production. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Discover a novel metal-free synthesis of Tegafur using organic ammonium salts. This patent offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN104178533B details enzymatic synthesis of R-3-aminobutanol. Offers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN101285085A reveals a high-efficiency whole cell catalysis method for Adenosylmethionine, offering superior conversion rates and simplified purification for global supply chains.
Patent CN106086126A reveals immobilized enzyme method for glutathione. Offers high purity, ATP regeneration, and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN103214400B reveals safer hexaflumuron manufacturing. Eliminates phosgene risks, ensures high purity supply chain stability for global agrochemical buyers.
Patent CN113528472B details a novel P450 BM3 mutant route for Trenbolone Acetate. Discover cost reduction in steroid manufacturing and high-purity intermediate supply strategies.